Our IHC analysis showed that the abundance of GFAP+ immunostaining across nine distinct grey matter regions was similar in the brains of conventionally housed or germ-free mice at the terminal stage of prion disease (Fig. 5). The gene discussed is GFAP; the disease is prion disease.